JDRF/Wellcome Trust

Diabetes and Inflammation Laboratory

Human Treg and DC

Interaction of a human T regulatory cell
(blue) and dendritic cell receptor CD80
(red) involving the type 1 diabetes
susceptibility receptor CTLA-4 (green)
in the immunological synapse (yellow).
Image courtesy of Paul MacAry.

The Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory (JDRF/WT DIL), centred in the Cambridge Institute for Medical Research, is a multi-disciplinary research programme within the University department of Medical Genetics.

The goals of the JDRF/WT DIL are to identify and characterise the effects of the susceptibility genes for type 1 diabetes in order to better understand the earliest events in human physiology that lead to autoimmune destruction of the insulin-producing beta-cells of pancreas.

Type 1 diabetes clinical trials

available at JDRF/WT DIL

Type 1 diabetes genes

Webimap ...